Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020 Dec 10:2020:6630838.
doi: 10.1155/2020/6630838. eCollection 2020.

Lithium-Associated Hypercalcemia Presenting with Neuropsychiatric Manifestations in a Patient with Bipolar Disorder

Roukaya Benjelloun  1 , Imane Motaib  1 , Yassine Otheman  2
Affiliations
Case Reports

Lithium-Associated Hypercalcemia Presenting with Neuropsychiatric Manifestations in a Patient with Bipolar Disorder

Roukaya Benjelloun et al. Case Rep Psychiatry. .

Abstract

One of the overlooked adverse effects of lithium treatment is neuropsychiatric manifestations induced by hypercalcemia (LAH). Here, we present the case of a patient, with bipolar disorder under lithium, who presented with neuropsychiatric symptoms that revealed hyperparathyroidism-induced hypercalcemia. This case illustrates the importance of monitoring parathyroid function and calcium levels in patients under lithium, especially in premenopaused women. LAH may mimic symptoms of manic episodes and should be sought in the case of brutal onset of confusion, anxiety, and/or hallucinations in the course of a bipolar disorder.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Albert U., De Cori D., Aguglia A., et al. Lithium-associated hyperparathyroidism and hypercalcaemia: a case-control cross-sectional study. Journal of Affective Disorders. 2013;151(2):786–790. doi: 10.1016/j.jad.2013.06.046. - DOI - PubMed
    1. Naramala S., Dalal H., Adapa S., Hassan A., Konala V. M. Lithium-induced hyperparathyroidism and hypercalcemia. Cureus. 2019;11(5, article e4590) doi: 10.7759/cureus.4590. - DOI - PMC - PubMed
    1. Haden S. T., Stoll A. L., McCormick S., Scott J., Fuleihan G. E.-H. Alterations in parathyroid dynamics in lithium-treated subjects. The Journal of Clinical Endocrinology and Metabolism. 1997;82(9):2844–2848. doi: 10.1210/jcem.82.9.4218. - DOI - PubMed
    1. Garfinkel P. E., Ezrin C., Stancer H. C. Hypothyroidism and hyperparathyroidism associated with lithium. The Lancet. 1973;302(7824):331–332. doi: 10.1016/s0140-6736(73)90846-5. - DOI - PubMed
    1. McKnight R. F., Adida M., Budge K., Stockton S., Goodwin G. M., Geddes J. R. Lithium toxicity profile: a systematic review and meta-analysis. The Lancet. 2012;379(9817):721–728. doi: 10.1016/S0140-6736(11)61516-X. - DOI - PubMed

Publication types

LinkOut - more resources